Publications
- Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)2023 | Faculty of Medicine in Pilsen
- Successful Early Use of Anti-SARS-CoV-2 Monoclonal Neutralizing Antibodies in SARS-CoV-2 Infected Hematological Patients - A Czech Multicenter Experience2022 | Third Faculty of Medicine
- Kaplacizumab v léčbě získané trombotické trombocytopenické purpury2022 | Faculty of Medicine in Hradec Králové
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Faculty of Pharmacy in Hradec Králové
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)2021 | Central Library of Charles University
- Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome2021 | Faculty of Medicine in Hradec Králové
- Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic2020 | Second Faculty of Medicine, Third Faculty of Medicine
- Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors2020 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
Loading network view...